5 Large-Cap Stocks Surge Up to 32% in a Month: Glenmark, Bosch, Vodafone Idea, Motilal Oswal, Paytm

Over the past month, while benchmark indices like Sensex and Nifty stayed nearly flat, 5 large-cap stocks delivered impressive gains, rising as much as 32%. Here’s what fueled their rallies:

Glenmark Pharmaceuticals Jumps 32%

Glenmark Pharma secured the list with a 32% monthly share price gain. The big trigger was a licensing agreement by its US subsidiary with AbbVie for a cancer drug. The deal brought in $700 million upfront, plus potential payouts and royalties, lifting investor sentiment.

Bosch Gains 18% Ahead of Results

Bosch rose 18% this month, marking a strong five-day rally. Investors are betting on robust quarterly results due in early August and the company’s role in electric vehicle and engine parts manufacturing.

Vodafone Idea Rises 17% on 5G Expansion

Vodafone Idea shares surged 17% in a month, thanks to the rollout of its 5G network in more cities, including Mysuru and Bengaluru. The company also expanded 4G capacity by 41% in Karnataka, driving optimism.

Motilal Oswal Adds 14% on AUM Milestone

Motilal Oswal Financial Services gained 14% after its asset management business crossed ₹1.5 lakh crore in assets under management (AUM). This milestone underscores strong long-term growth.

Paytm Climbs 14% on Profit Expectations

One97 Communications (Paytm) advanced 14%, supported by positive sentiment ahead of its Q1 results. Investors are hopeful the company will post profits and continue improving operational efficiency.

Read More: Upcoming Bonus Shares This Week: Ashok Leyland, Samvardhana Motherson & More; Check Record Date, Eligibility.

Conclusion

 While broader indices struggled for direction, these five large-cap stocks stood out with strong catalysts ranging from major deals to business milestones. Investors are closely watching whether these gains will be sustained in the coming months.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.